Covadonga Pañeda
Geschäftsführer bei ALTAMIRA THERAPEUTICS LTD.
Aktive Positionen von Covadonga Pañeda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Geschäftsführer | 01.01.2023 | - |
| Corporate Officer/Principal | - | 01.01.2023 |
Karriereverlauf von Covadonga Pañeda
Ehemalige bekannte Positionen von Covadonga Pañeda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Corporate Officer/Principal | 01.10.2020 | 01.04.2022 |
Sylentis SA
 Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2011 | 01.06.2018 |
Ausbildung von Covadonga Pañeda
| Universidad Autónoma de Madrid | Doctorate Degree |
Statistik
International
| Spanien | 3 |
| Bermuda | 2 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
- Börse
- Insiders
- Covadonga Pañeda
- Erfahrung
